Mitcon Consultancy & Engineering Services Ltd: Intrinsic Value & Share Price Analysis

Last Updated: December 29, 2025, 11:18 am

All Competitor Stocks of Mitcon Consultancy & Engineering Services Ltd

Last Updated: August 20, 2025, 6:55 am

Below is a detailed analysis of the quarterly data for Mitcon Consultancy & Engineering Services Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 24.43 Cr.. The value appears to be declining and may need further review. It has decreased from 38.13 Cr. (Mar 2025) to 24.43 Cr., marking a decrease of 13.70 Cr..
• For Expenses, as of Jun 2025, the value is 18.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 30.80 Cr. (Mar 2025) to 18.02 Cr., marking a decrease of 12.78 Cr..
• For Operating Profit, as of Jun 2025, the value is 6.41 Cr.. The value appears to be declining and may need further review. It has decreased from 7.33 Cr. (Mar 2025) to 6.41 Cr., marking a decrease of 0.92 Cr..
• For OPM %, as of Jun 2025, the value is 26.24%. The value appears strong and on an upward trend. It has increased from 19.22% (Mar 2025) to 26.24%, marking an increase of 7.02%.
• For Other Income, as of Jun 2025, the value is 0.41 Cr.. The value appears to be declining and may need further review. It has decreased from 0.59 Cr. (Mar 2025) to 0.41 Cr., marking a decrease of 0.18 Cr..
• For Interest, as of Jun 2025, the value is 2.82 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.86 Cr. (Mar 2025) to 2.82 Cr., marking a decrease of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 2.34 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.37 Cr. (Mar 2025) to 2.34 Cr., marking a decrease of 0.03 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.66 Cr.. The value appears to be declining and may need further review. It has decreased from 2.69 Cr. (Mar 2025) to 1.66 Cr., marking a decrease of 1.03 Cr..
• For Tax %, as of Jun 2025, the value is 27.71%. The value appears to be improving (decreasing) as expected. It has decreased from 36.43% (Mar 2025) to 27.71%, marking a decrease of 8.72%.
• For Net Profit, as of Jun 2025, the value is 1.20 Cr.. The value appears to be declining and may need further review. It has decreased from 1.70 Cr. (Mar 2025) to 1.20 Cr., marking a decrease of 0.50 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.81. The value appears to be declining and may need further review. It has decreased from 1.26 (Mar 2025) to 0.81, marking a decrease of 0.45.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: December 15, 2025, 4:58 am

Last Updated: December 4, 2025, 1:39 am

Below is a detailed analysis of the balance sheet data for Mitcon Consultancy & Engineering Services Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 3.00 Cr..
• For Reserves, as of Sep 2025, the value is 134.00 Cr.. The value appears strong and on an upward trend. It has increased from 112.00 Cr. (Mar 2025) to 134.00 Cr., marking an increase of 22.00 Cr..
• For Borrowings, as of Sep 2025, the value is 104.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 113.00 Cr. (Mar 2025) to 104.00 Cr., marking a decrease of 9.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 45.00 Cr.. The value appears to be improving (decreasing). It has decreased from 47.00 Cr. (Mar 2025) to 45.00 Cr., marking a decrease of 2.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 300.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 286.00 Cr. (Mar 2025) to 300.00 Cr., marking an increase of 14.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 162.00 Cr.. The value appears to be declining and may need further review. It has decreased from 164.00 Cr. (Mar 2025) to 162.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Sep 2025, the value is 128.00 Cr.. The value appears strong and on an upward trend. It has increased from 114.00 Cr. (Mar 2025) to 128.00 Cr., marking an increase of 14.00 Cr..
• For Total Assets, as of Sep 2025, the value is 300.00 Cr.. The value appears strong and on an upward trend. It has increased from 286.00 Cr. (Mar 2025) to 300.00 Cr., marking an increase of 14.00 Cr..

Notably, the Reserves (134.00 Cr.) exceed the Borrowings (104.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for Mitcon Consultancy & Engineering Services Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.63. This value is below the healthy minimum of 5. It has increased from 4.20 (Mar 24) to 4.63, marking an increase of 0.43.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.00. This value is below the healthy minimum of 5. It has decreased from 4.18 (Mar 24) to 4.00, marking a decrease of 0.18.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.56. This value is within the healthy range. It has increased from 10.52 (Mar 24) to 11.56, marking an increase of 1.04.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 87.43. It has increased from 86.07 (Mar 24) to 87.43, marking an increase of 1.36.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 87.43. It has increased from 86.07 (Mar 24) to 87.43, marking an increase of 1.36.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 77.74. It has decreased from 96.36 (Mar 24) to 77.74, marking a decrease of 18.62.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 21.92. This value is within the healthy range. It has decreased from 24.21 (Mar 24) to 21.92, marking a decrease of 2.29.
• For PBIT / Share (Rs.), as of Mar 25, the value is 15.64. This value is within the healthy range. It has decreased from 18.46 (Mar 24) to 15.64, marking a decrease of 2.82.
• For PBT / Share (Rs.), as of Mar 25, the value is 6.27. This value is within the healthy range. It has decreased from 7.91 (Mar 24) to 6.27, marking a decrease of 1.64.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 5.28. This value is within the healthy range. It has increased from 4.78 (Mar 24) to 5.28, marking an increase of 0.50.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.83. This value is within the healthy range. It has decreased from 3.97 (Mar 24) to 3.83, marking a decrease of 0.14.
• For PBDIT Margin (%), as of Mar 25, the value is 28.19. This value is within the healthy range. It has increased from 25.12 (Mar 24) to 28.19, marking an increase of 3.07.
• For PBIT Margin (%), as of Mar 25, the value is 20.11. This value exceeds the healthy maximum of 20. It has increased from 19.15 (Mar 24) to 20.11, marking an increase of 0.96.
• For PBT Margin (%), as of Mar 25, the value is 8.07. This value is below the healthy minimum of 10. It has decreased from 8.21 (Mar 24) to 8.07, marking a decrease of 0.14.
• For Net Profit Margin (%), as of Mar 25, the value is 6.79. This value is within the healthy range. It has increased from 4.95 (Mar 24) to 6.79, marking an increase of 1.84.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 8. It has increased from 4.12 (Mar 24) to 4.92, marking an increase of 0.80.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.38. This value is below the healthy minimum of 15. It has decreased from 4.61 (Mar 24) to 4.38, marking a decrease of 0.23.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.96. This value is below the healthy minimum of 10. It has increased from 9.69 (Mar 24) to 9.96, marking an increase of 0.27.
• For Return On Assets (%), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 5. It has increased from 1.71 (Mar 24) to 1.94, marking an increase of 0.23.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.59. This value is within the healthy range. It has decreased from 0.92 (Mar 24) to 0.59, marking a decrease of 0.33.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.83. This value is within the healthy range. It has decreased from 1.13 (Mar 24) to 0.83, marking a decrease of 0.30.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.37. It has decreased from 0.46 (Mar 24) to 0.37, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 24) to 1.37, marking a decrease of 0.17.
• For Quick Ratio (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.26, marking a decrease of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 15.66. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 15.66, marking an increase of 15.66.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.34. This value is below the healthy minimum of 3. It has increased from 2.29 (Mar 24) to 2.34, marking an increase of 0.05.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 3. It has increased from 1.45 (Mar 24) to 1.56, marking an increase of 0.11.
• For Enterprise Value (Cr.), as of Mar 25, the value is 213.82. It has decreased from 288.88 (Mar 24) to 213.82, marking a decrease of 75.06.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.90, marking a decrease of 0.33.
• For EV / EBITDA (X), as of Mar 25, the value is 6.73. This value is within the healthy range. It has decreased from 8.89 (Mar 24) to 6.73, marking a decrease of 2.16.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.17 (Mar 24) to 0.90, marking a decrease of 0.27.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 0.80. This value is below the healthy minimum of 1. It has decreased from 1.31 (Mar 24) to 0.80, marking a decrease of 0.51.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.17 (Mar 24) to 0.90, marking a decrease of 0.27.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

About the Company - Qualitative Analysis